In the latest trading session, 0.53 million Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares changed hands as the company’s beta touched 1.08. With the company’s most recent per share price at $0.36 changed hands at -$0.01 or -1.39% at last look, the market valuation stands at $130.65M. LXRX’s current price is a discount, trading about -627.78% off its 52-week high of $2.62. The share price had its 52-week low at $0.28, which suggests the last value was 22.22% up since then. When we look at Lexicon Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 15.44 million shares, with the 3-month average coming to 6.53 million.
Analysts gave the Lexicon Pharmaceuticals Inc (LXRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.17. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended LXRX as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) trade information
Instantly LXRX was in red as seen in intraday trades today. With action 1.89%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -51.06%, with the 5-day performance at 1.89% in the green. However, in the 30-day time frame, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) is -51.25% down. Looking at the short shares, we see there were 47.46 million shares sold at short interest cover period of 11.94 days.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 94.0% from its recent market value. According to analyst projections, LXRX’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -1566.67% plunge from its current level, while the stock would need to soar -1566.67% for it to hit the projected low.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.19% of Lexicon Pharmaceuticals Inc shares while 84.10% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 85.11%. There are 84.10% institutions holding the Lexicon Pharmaceuticals Inc stock share, with ARTAL GROUP S.A. the top institutional holder. As of 2024-06-30, the company held 56.3318% of the shares, roughly 175.1 million LXRX shares worth $294.17 million.
FMR LLC holds the second largest percentage of outstanding shares, with 15.7656% or 38.69 million shares worth $64.99 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Growth Company Fund and Fidelity Growth Company K6 Fund. With 16.9 shares estimated at $6.09 million under it, the former controlled 4.67% of total outstanding shares. On the other hand, Fidelity Growth Company K6 Fund held about 1.52% of the shares, roughly 5.5 shares worth around $1.98 million.
